Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term azithromycin for bronchiectasis
NL-OMON30795Phase 3Recruiting
- Sponsor
- Noordwest Ziekenhuisgroep
- Start
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bronchiectasis and chronic bronchitis (CB) comparing Azithromycin with Placebo (2 arms). Primary endpoints: Number of exacerbations, Change in forced expiratory volume in 1 second and 1 more. Started Apr 2008; status: recruiting.
02
Drugs
azithromycin
03
Conditions
bronchiectasischronic bronchitis (CB)
Beyond the preview
Go deeper on NL-OMON30795.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON30795.